Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3V01

Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.

3V01 の概要
エントリーDOI10.2210/pdb3v01/pdb
関連するPDBエントリー3V04
分子名称Dual specificity mitogen-activated protein kinase kinase 1, N-{[(2R)-2,3-dihydroxypropyl]oxy}-3-[(2-fluoro-4-iodophenyl)amino]furo[3,2-c]pyridine-2-carboxamide, ADENOSINE-5'-TRIPHOSPHATE, ... (4 entities in total)
機能のキーワードkinase, transferase-inhibitor complex, transferase/inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm, cytoskeleton, centrosome: Q02750
タンパク質・核酸の鎖数1
化学式量合計38949.32
構造登録者
主引用文献Heald, R.A.,Jackson, P.,Savy, P.,Jones, M.,Gancia, E.,Burton, B.,Newman, R.,Boggs, J.,Chan, E.,Chan, J.,Choo, E.,Merchant, M.,Rudewicz, P.,Ultsch, M.,Wiesmann, C.,Yue, Q.,Belvin, M.,Price, S.
Discovery of Novel Allosteric Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors Possessing Bidentate Ser212 Interactions.
J.Med.Chem., 55:4594-4604, 2012
Cited by
PubMed Abstract: Using structure-based design, two novel series of highly potent biaryl amine mitogen-activated protein kinase kinase (MEK) inhibitors have been discovered. These series contain an H-bond acceptor, in a shifted position compared with previously disclosed compounds, and an adjacent H-bond donor, resulting in a bidentate interaction with the Ser212 residue of MEK1. The most potent compound identified, 1 (G-894), is orally active in in vivo pharmacodynamic and tumor xenograft models.
PubMed: 22506516
DOI: 10.1021/jm2017094
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.705 Å)
構造検証レポート
Validation report summary of 3v01
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon